Isoniazid‐loaded orodispersible strips: Methodical design, optimization and in vitro‐in silico characterization
暂无分享,去创建一个
Oluwatoyin A. Adeleke | Krizia M. Karry | Nkwe O. Monama | Pei‐Chin Tsai | Bozena B. Michniak‐Kohn | B. Michniak-Kohn | Pei-Chin Tsai | N. Monama
[1] R. Kalita,et al. Extraction and characterization of microcrystalline cellulose from fodder grass; Setaria glauca (L) P. Beauv, and its potential as a drug delivery vehicle for isoniazid, a first line antituberculosis drug. , 2013, Colloids and surfaces. B, Biointerfaces.
[2] Handbook of anti-tuberculosis agents. Introduction. , 2008, Tuberculosis.
[3] P. S. Hiremath,et al. Controlled Release Hydrophilic Matrix Tablet Formulations of Isoniazid: Design and In Vitro Studies , 2008, AAPS PharmSciTech.
[4] C. I. Sainz-Díaz,et al. Assessment of halloysite nanotubes as vehicles of isoniazid. , 2017, Colloids and surfaces. B, Biointerfaces.
[5] K. Gilani,et al. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid , 2011, Journal of microencapsulation.
[6] Sandeep Arora,et al. Orally dissolving strips: A new approach to oral drug delivery system , 2013, International journal of pharmaceutical investigation.
[7] Jukka Rantanen,et al. Anti‐tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[8] B. Mishra,et al. Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design* , 2014, Expert opinion on drug delivery.
[9] J. Coates. Interpretation of Infrared Spectra, A Practical Approach , 2006 .
[10] A. Mitra,et al. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate , 2015, AAPS PharmSciTech.
[11] Panos Macheras,et al. Analysis of Case II drug transport with radial and axial release from cylinders. , 2003, International journal of pharmaceutics.
[12] Jianhua Sun,et al. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy , 2009, Biomedical materials.
[13] M. Repka,et al. Formulation and development of orodispersible sustained release tablet of domperidone , 2016, Drug development and industrial pharmacy.
[14] G. Murtaza,et al. Formulation and characterization of modified release tablets containing isoniazid using swellable polymers. , 2011, African journal of traditional, complementary, and alternative medicines : AJTCAM.
[15] J. Varshosaz,et al. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles , 2017, Research in pharmaceutical sciences.
[16] J. Breitkreutz,et al. Comparative investigations on different polymers for the preparation of fast‐dissolving oral films , 2010, The Journal of pharmacy and pharmacology.
[17] Muhammad Zaman,et al. Thiolation of arabinoxylan and its application in the fabrication of controlled release mucoadhesive oral films , 2017, DARU Journal of Pharmaceutical Sciences.
[18] L. Kumar,et al. Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis , 2013, Artificial cells, nanomedicine, and biotechnology.
[19] Heinz Pichler,et al. Orodispersible films: Towards drug delivery in special populations. , 2017, International journal of pharmaceutics.
[20] Guping Tang,et al. Poly(N-vinylpyrrolidinone) microgels: preparation, biocompatibility, and potential application as drug carriers. , 2014, Biomacromolecules.
[21] Min Liu,et al. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics , 2014, Drug development and industrial pharmacy.
[22] Hatem Fessi,et al. Orodispersible films based on amorphous solid dispersions of tetrabenazine. , 2017, International journal of pharmaceutics.
[23] R. Dixit,et al. Oral strip technology: overview and future potential. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[24] Pei-Chin Tsai,et al. Combined Atomistic Molecular Calculations and Experimental Investigations for the Architecture, Screening, Optimization, and Characterization of Pyrazinamide Containing Oral Film Formulations for Tuberculosis Management. , 2016, Molecular pharmaceutics.
[25] A. Joshi,et al. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[26] F. Alanazi,et al. Effects of Kollicoat IR® and hydroxypropyl-β-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules , 2010, Pharmaceutical development and technology.
[27] M. Ikram,et al. Formulation and optimization of mucoadhesive buccal patches of losartan potassium by using response surface methodology , 2015, Advanced biomedical research.
[28] S. Simões,et al. Oral films: Current status and future perspectives II - Intellectual property, technologies and market needs. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[29] A. Nokhodchi,et al. Evaluation of the surface chemistry and drug-polymer interaction of semi-crystalline micro-particles for the development of controlled release formulations. , 2017, Materials science & engineering. C, Materials for biological applications.
[30] R. Bala,et al. Design Optimization and In Vitro-In Vivo Evaluation of Orally Dissolving Strips of Clobazam , 2014, Journal of drug delivery.
[31] J. Farrar,et al. Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets , 2014, PLoS ONE.
[32] A. Goyal,et al. Pulmonary delivery of antitubercular drugs using spray-dried lipid–polymer hybrid nanoparticles , 2016, Artificial cells, nanomedicine, and biotechnology.
[33] Cadmus Yuan,et al. Molecular modeling of temperature dependence of solubility parameters for amorphous polymers , 2011, Journal of Molecular Modeling.
[34] B. De Spiegeleer,et al. Enniatin-containing solutions for oromucosal use: Quality-by-design ex-vivo transmucosal risk assessment of composition variability. , 2015, International journal of pharmaceutics.
[35] Y. Tu,et al. Polyethylene glycol as a promising synthetic material for repair of spinal cord injury , 2017, Neural regeneration research.
[36] A. Joshi,et al. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. , 2010, International journal of pharmaceutics.
[37] Xiaodong Cao,et al. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery. , 2014, International journal of pharmaceutics.
[38] R. Jachowicz,et al. Orodispersible films and tablets with prednisolone microparticles. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] T. Garg,et al. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs , 2016, Artificial cells, nanomedicine, and biotechnology.
[40] Ana Filipa Borges,et al. Oral films: Current status and future perspectives: I - Galenical development and quality attributes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[41] R. Bhandari,et al. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. , 2013, International journal of pharmaceutics.
[42] S. Jeong,et al. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release. , 2017, Chemical & pharmaceutical bulletin.
[43] P. Kleinebudde,et al. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[44] N. Mulder,et al. Co-infection with Mycobacterium tuberculosis and human immunodeficiency virus: an overview and motivation for systems approaches. , 2013, Pathogens and disease.
[45] P. Kshetrapal,et al. Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation , 2018, Artificial cells, nanomedicine, and biotechnology.
[46] M. Fathy,et al. Enhancement of the Dissolution and Permeation Rates of Meloxicam by Formation of Its Freeze-dried Solid Dispersions in Polyvinylpyrrolidone K-30 , 2006, Drug development and industrial pharmacy.
[47] Xiaojian Ye,et al. 3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy. , 2015, Acta biomaterialia.
[48] M. L. González-Rodríguez,et al. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery. , 2012, Journal of pharmaceutical sciences.
[49] T. Webster,et al. Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide , 2014, International journal of nanomedicine.
[50] D. Barends,et al. Biowaiver monographs for immediate release solid oral dosage forms: isoniazid. , 2007, Journal of pharmaceutical sciences.
[51] S. Bates,et al. Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns , 2006, Pharmaceutical Research.
[52] Dawei Li,et al. Dopamine-assisted fixation of drug-loaded polymeric multilayers to osteoarticular implants for tuberculosis therapy. , 2017, Biomaterials science.
[53] Shrawan Baghel,et al. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. , 2016, Journal of pharmaceutical sciences.
[54] Sandip S Chavhan,et al. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design , 2018, AAPS PharmSciTech.
[55] K. Kulkarni,et al. Controlled-release tablet formulation of isoniazid. , 1992, Die Pharmazie.
[56] Weigang Wu,et al. Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro , 2014, Biomedical engineering online.
[57] D. Chiappetta,et al. Nanopolymersomes as potential carriers for rifampicin pulmonary delivery. , 2015, Colloids and surfaces. B, Biointerfaces.
[58] J. A. Zeitler,et al. The Role of Configurational Entropy in Amorphous Systems , 2010, Pharmaceutics.
[59] R. Banerjee,et al. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.
[60] C. Tripodo,et al. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[61] B. Mishra,et al. Macrophage-Specific Targeting of Isoniazid Through Mannosylated Gelatin Microspheres , 2011, AAPS PharmSciTech.
[62] P. Narayan,et al. Polymers and Surfactants , 2015 .
[63] Sanjay Sharma,et al. Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.